Potential drawbacks of SARS-CoV-2 seroprevalence surveys. | J Hosp Infect;110: 206, 2021 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Potential drawbacks of SARS-CoV-2 seroprevalence surveys.

Lippi, G.

Lippi G; Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy. Electronic address: giuseppe.lippi@univr.it.

J Hosp Infect ; 110: 206, 2021 04.

Article in English | MEDLINE | ID: covidwho-1385935

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Health Personnel; Humans; Seroepidemiologic Studies

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Hosp Infect Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Hosp Infect Year: 2021 Document Type: Article